PUBLICATIONS INTERNATIONALES 2010 1 Afonso PV

PUBLICATIONS INTERNATIONALES 2010
1 Afonso PV, Mekaouche M, Mortreux F, Toulza F, Moriceau A, Wattel E, Gessain
A, Bangham CR, Dubreuil G, Plumelle Y, Hermine O, Estaquier J, Mahieux R
(2010) Highly active antiretroviral treatment against STLV-1 infection combining
reverse transcriptase and HDAC inhibitors. Blood 116: 3802-3808
2 Alapetite C, Brisse H, Patte C, Raquin MA, Gaboriaud G, Carrie C, Habrand JL,
Thiesse P, Cuilliere JC, Bernier V, Ben Hassel M, Frappaz D, Baranzelli MC,
Bouffet E (2010) Pattern of relapse and outcome of non-metastatic germinoma
patients treated with chemotherapy and limited field radiation: the SFOP
experience. Neuro Oncol 12: 1318-1325
3 Alexandre J, Ray-Coquard I, Selle F, Floquet A, Cottu P, Weber B, Falandry C,
Lebrun D, Pujade-Lauraine E (2010) Mucinous advanced epithelial ovarian
carcinoma: clinical presentation and sensitivity to platinum-paclitaxel-based
chemotherapy, the GINECO experience. Ann Oncol 21: 2377-2381
4 Alfano L, Guida T, Provitera L, Vecchio G, Billaud M, Santoro M, Carlomagno F
(2010) RET is a heat shock protein 90 (HSP90) client protein and is knocked
down upon HSP90 pharmacological block. J Clin Endocrinol Metab 95: 3552-
3557
5 Annereau JP, Brel V, Dumontet C, Guminski Y, Imbert T, Broussas M, Vispe S,
Breand S, Guilbaud N, Barret JM, Bailly C (2010) A fluorescent biomarker of the
polyamine transport system to select patients with AML for F14512 treatment.
Leuk Res 34: 1383-1389
6 Ansieau S, Morel AP, Hinkal G, Bastid J, Puisieux A (2010) TWISTing an
embryonic transcription factor into an oncoprotein. Oncogene 29: 3173-3184
7 Antoniou AC, Beesley J, McGuffog L, Sinilnikova OM, Healey S, Neuhausen SL,
Ding YC, Rebbeck TR, Weitzel JN, Lynch HT, Isaacs C, Ganz PA, Tomlinson G,
Olopade OI, Couch FJ, Wang X, Lindor NM, Pankratz VS, Radice P, Manoukian
S, Peissel B, Zaffaroni D, Barile M, Viel A, Allavena A, Dall'Olio V, Peterlongo
P, Szabo CI, Zikan M, Claes K, Poppe B, Foretova L, Mai PL, Greene MH,
Rennert G, Lejbkowicz F, Glendon G, Ozcelik H, Andrulis IL, Thomassen M,
Gerdes AM, Sunde L, Cruger D, Birk JU, Caligo M, Friedman E, Kaufman B,
Laitman Y, Milgrom R, Dubrovsky M, Cohen S, Borg A, Jernstrom H, Lindblom
A, Rantala J, Stenmark-Askmalm M, Melin B, Nathanson K, Domchek S,
Jakubowska A, Lubinski J, Huzarski T, Osorio A, Lasa A, Duran M, Tejada MI,
Godino J, Benitez J, Hamann U, Kriege M, Hoogerbrugge N, van der Luijt RB,

2
van Asperen CJ, Devilee P, Meijers-Heijboer EJ, Blok MJ, Aalfs CM, Hogervorst
F, Rookus M, Cook M, Oliver C, Frost D, Conroy D, Evans DG, Lalloo F,
Pichert G, Davidson R, Cole T, Cook J, Paterson J, Hodgson S, Morrison PJ,
Porteous ME, Walker L, Kennedy MJ, Dorkins H, Peock S, Godwin AK, Stoppa-
Lyonnet D, de PA, Mazoyer S, Bonadona V, Lasset C, Dreyfus H, Leroux D,
Hardouin A, Berthet P, Faivre L, Loustalot C, Noguchi T, Sobol H, Rouleau E,
Nogues C, Frenay M, Venat-Bouvet L, Hopper JL, Daly MB, Terry MB, John
EM, Buys SS, Yassin Y, Miron A, Goldgar D, Singer CF, Dressler AC,
Gschwantler-Kaulich D, Pfeiler G, Hansen TV, Jonson L, Agnarsson BA,
Kirchhoff T, Offit K, Devlin V, Dutra-Clarke A, Piedmonte M, Rodriguez GC,
Wakeley K, Boggess JF, Basil J, Schwartz PE, Blank SV, Toland AE, Montagna
M, Casella C, Imyanitov E, Tihomirova L, Blanco I, Lazaro C, Ramus SJ,
Sucheston L, Karlan BY, Gross J, Schmutzler R, Wappenschmidt B, Engel C,
Meindl A, Lochmann M, Arnold N, Heidemann S, Varon-Mateeva R,
Niederacher D, Sutter C, Deissler H, Gadzicki D, Preisler-Adams S, Kast K,
Schonbuchner I, Caldes T, de la Hoya M, Aittomaki K, Nevanlinna H, Simard J,
Spurdle AB, Holland H, Chen X, Platte R, Chenevix-Trench G, Easton DF
(2010) Common breast cancer susceptibility alleles and the risk of breast cancer
for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.
Cancer Res 70: 9742-9754
8 Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, Sinilnikova
OM, Healey S, Morrison J, Kartsonaki C, Lesnick T, Ghoussaini M, Barrowdale
D, Peock S, Cook M, Oliver C, Frost D, Eccles D, Evans DG, Eeles R, Izatt L,
Chu C, Douglas F, Paterson J, Stoppa-Lyonnet D, Houdayer C, Mazoyer S,
Giraud S, Lasset C, Remenieras A, Caron O, Hardouin A, Berthet P, Hogervorst
FB, Rookus MA, Jager A, van den OA, Hoogerbrugge N, van der Luijt RB,
Meijers-Heijboer H, Gomez Garcia EB, Devilee P, Vreeswijk MP, Lubinski J,
Jakubowska A, Gronwald J, Huzarski T, Byrski T, Gorski B, Cybulski C, Spurdle
AB, Holland H, Goldgar DE, John EM, Hopper JL, Southey M, Buys SS, Daly
MB, Terry MB, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Preisler-
Adams S, Arnold N, Niederacher D, Sutter C, Domchek SM, Nathanson KL,
Rebbeck T, Blum JL, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF,
Basil J, Blank SV, Friedman E, Kaufman B, Laitman Y, Milgrom R, Andrulis IL,
Glendon G, Ozcelik H, Kirchhoff T, Vijai J, Gaudet MM, Altshuler D, Guiducci
C, Loman N, Harbst K, Rantala J, Ehrencrona H, Gerdes AM, Thomassen M,
Sunde L, Peterlongo P, Manoukian S, Bonanni B, Viel A, Radice P, Caldes T, de
la HM, Singer CF, Fink-Retter A, Greene MH, Mai PL, Loud JT, Guidugli L,
Lindor NM, Hansen TV, Nielsen FC, Blanco I, Lazaro C, Garber J, Ramus SJ,
Gayther SA, Phelan C, Narod S, Szabo CI, Benitez J, Osorio A, Nevanlinna H,
Heikkinen T, Caligo MA, Beattie MS, Hamann U, Godwin AK, Montagna M,
Casella C, Neuhausen SL, Karlan BY, Tung N, Toland AE, Weitzel J, Olopade
O, Simard J, Soucy P, Rubinstein WS, Arason A, Rennert G, Martin NG,
Montgomery GW, Chang-Claude J, Flesch-Janys D, Brauch H, Severi G,
Baglietto L, Cox A, Cross SS, Miron P, Gerty SM, Tapper W, Yannoukakos D,
Fountzilas G, Fasching PA, Beckmann MW, Dos SS, I, Peto J, Lambrechts D,
Paridaens R, Rudiger T, Forsti A, Winqvist R, Pylkas K, Diasio RB, Lee AM,

3
Eckel-Passow J, Vachon C, Blows F, Driver K, Dunning A, Pharoah PP, Offit K,
Pankratz VS, Hakonarson H, Chenevix-Trench G, Easton DF, Couch FJ (2010) A
locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is
associated with hormone receptor-negative breast cancer in the general
population. Nat Genet 42: 885-892
9 Arnaud O, Koubeissi A, Ettouati L, Terreux R, Alame G, Grenot C, Dumontet C,
Di PA, Paris J, Falson P (2010) Potent and fully noncompetitive peptidomimetic
inhibitor of multidrug resistance P-glycoprotein. J Med Chem 53: 6720-6729
10 Autier P, Tryggvadottir L, Sigurdsson T, Olafsdottir E, Sigurgeirsson B, Jonasson
JG, Olafsson JH, Byrnes GB, Hery C, Dore JF, Boniol M (2010) Autier et al.
Respond to "A Sunbed Epidemic?". Am J Epidemiol
11 Bachelard-Cascales E, Chapellier M, Delay E, Pochon G, Voeltzel T, Puisieux A,
Caron dF, Maguer-Satta V (2010) The CD10 enzyme is a key player to identify
and regulate human mammary stem cells. Stem Cells 28: 1081-1088
12 Banneau G, Guedj M, Macgrogan G, de M, I, Velasco V, Schiappa R, Bonadona
V, David A, Dugast C, Gilbert-Dussardier B, Ingster O, Vabres P, Caux F, de
Reynies A, Iggo R, Sevenet N, Bonnet F, Longy M (2010) Molecular apocrine
differentiation is a common feature of breast cancer in patients with germline
PTEN mutations. Breast Cancer Res 12: R63
13 Bastid J, Bouchet BP, Ciancia C, Pourchet J, Audoynaud C, Grelier G, Puisieux
A, Ansieau S (2010) The SNAIL family member SCRATCH1 is not expressed in
human tumors. Oncol Rep 23: 523-529
14 Bauchet L, Mathieu-Daude H, Fabbro-Peray P, Rigau V, Fabbro M, Chinot O,
Pallusseau L, Carnin C, Laine K, Schlama A, Thiebaut A, Patru MC, Bauchet F,
Lionnet M, Wager M, Faillot T, Taillandier L, Figarella-Branger D, Capelle L,
Loiseau H, Frappaz D, Campello C, Kerr C, Duffau H, Reme-Saumon M,
Tretarre B, Daures JP, Henin D, Labrousse F, Menei P, Honnorat J (2010)
Oncological patterns of care and outcome for 952 patients with newly diagnosed
glioblastoma in 2004. Neuro Oncol
15 Belbaraka R, Tredan O, Ray-Coquard I, Chvetzoff G, Bajard A, Perol D, Ismaili
N, Ismaili M, Errihani H, Bachelot T, Rebattu P (2010) Factors of interrupting
chemotherapy in patients with Advanced Non-Small-Cell Lung Cancer. BMC Res
Notes 3: 164
16 Benjamin RS, Schoffski P, Hartmann JT, Van Oosterom A, Bui BN, Duyster J,
Schuetze S, Blay JY, Reichardt P, Rosen LS, Skubitz K, McCoy S, Sun YN,
Stepan DE, Baker L (2010) Efficacy and safety of motesanib, an oral inhibitor of
VEGF, PDGF, and Kit receptors, in patients with imatinib-resistant
gastrointestinal stromal tumors. Cancer Chemother Pharmacol

4
17 Berthier-Vergnes O, Kharbili ME, de la Fouchardiere A, Pointecouteau T,
Verrando P, Wierinckx A, Lachuer J, Le NF, Lamartine J (2010) Gene expression
profiles of human melanoma cells with different invasive potential reveal
TSPAN8 as a novel mediator of invasion. Br J Cancer
18 Bertrand A, Marec-Berard P, Raverot G, Trouillas J, Marabelle A (2010)
Cabergoline therapy of paraneoplastic Cushing syndrome in children. Pediatr
Blood Cancer 55: 589-590
19 Bertucci F, Borie N, Roche H, Bachelot T, Le Doussal JM, Macgrogan G,
Debono S, Martinec A, Treilleux I, Finetti P, Esterni B, Extra JM, Geneve J,
Hermitte F, Chabannon C, Jacquemier J, Martin AL, Longy M, Maraninchi D,
Fert V, Birnbaum D, Viens P (2010) Gene expression profile predicts outcome
after anthracycline-based adjuvant chemotherapy in early breast cancer. Breast
Cancer Res Treat
20 Billaud M, Viollet B (2010) Close encounters of a novel kind: A multi-targeted
cancer drug meets a metabolic sensor. Cancer Biol Ther 10:
21 Blay JY (2010) Pharmacological management of gastrointestinal stromal tumours:
an update on the role of sunitinib. Ann Oncol 21: 208-215
22 Blay JY (2010) Updating progress in sarcoma therapy with mTOR inhibitors. Ann
Oncol
23 Blay JY, von Mehren M, Blackstein ME (2010) Perspective on updated treatment
guidelines for patients with gastrointestinal stromal tumors. Cancer 116: 5126-
5137
24 Bodard AG, Paris M, Salino S, Fortin T (2010) Evaluation of two noninvasive
repositioning systems for computer-assisted oral implant surgery in oral cancer
patients. Int J Prosthodont 23: 463-468
25 Boisseau N, Burde A, Bachmann P, Senesse P, Hebuterne X (2010) A telephone-
linked computer system for home enteral nutrition. J Telemed Telecare 16: 363-
367
26 Boivin A, Currie K, Fervers B, Gracia J, James M, Marshall C, Sakala C, Sanger
S, Strid J, Thomas V, van der WT, Grol R, Burgers J (2010) Patient and public
involvement in clinical guidelines: international experiences and future
perspectives. Qual Saf Health Care 19: e22
27 Bonaiti B, Bonadona V, Perdry H, Andrieu N, Bonaiti-Pellie C (2010) Estimating
penetrance from multiple case families with predisposing mutations: extension of
the 'genotype-restricted likelihood' (GRL) method. Eur J Hum Genet
28 Bouzas-Rodriguez J, Cabrera JR, Delloye-Bourgeois C, Ichim G, Delcros JG,
Raquin MA, Rousseau R, Combaret V, Benard J, Tauszig-Delamasure S, Mehlen

5
P (2010) Neurotrophin-3 production promotes human neuroblastoma cell survival
by inhibiting TrkC-induced apoptosis. J Clin Invest 120: 850-858
29 Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers
B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L
(2010) AGREE II: Advancing guideline development, reporting, and evaluation
in health care. Prev Med 51: 421-424
30 Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers
B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L
(2010) AGREE II: Advancing guideline development, reporting and evaluation in
health care. J Clin Epidemiol 63: 1308-1311
31 Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers
B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L
(2010) AGREE II: Advancing guideline development, reporting and evaluation in
health care. CMAJ 182: E839-E842
32 Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers
B, Graham ID, Hanna SE, Makarski J (2010) Development of the AGREE II, part
1: performance, usefulness and areas for improvement. CMAJ 182: 1045-1052
33 Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers
B, Graham ID, Hanna SE, Makarski J (2010) Development of the AGREE II, part
2: assessment of validity of items and tools to support application. CMAJ 182:
E472-E478
34 Buiret G, Combe C, Favrel V, Pommier P, Martin L, Ecochard R, Fayette J,
Tartas S, Ramade A, Ceruse P (2010) A retrospective, multicenter study of the
tolerance of induction chemotherapy with docetaxel, Cisplatin, and 5-
Fluorouracil followed by radiotherapy with concomitant cetuximab in 46 cases of
squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 77:
430-437
35 Butturini A, Frappaz D (2010) The challenges of high-dose chemotherapy in CNS
tumors. Pediatr Blood Cancer 54: 652-653
36 Campone M, Juin P, Andre F, Bachelot T (2010) Resistance to HER2 inhibitors:
Is addition better than substitution? Rationale for the hypothetical concept of drug
sedimentation. Crit Rev Oncol Hematol
37 Carrabin N, Mithieux F, Meeus P, Tredan O, Guastalla JP, Bachelot T, Labidi SI,
Treilleux I, Rivoire M, Ray-Coquard I (2010) Hyperthermic intraperitoneal
chemotherapy with oxaliplatin and without adjuvant chemotherapy in stage IIIC
ovarian cancer. Bull Cancer 97: E23-E32